Are third-generation cephalosporins associated with a better prognosis than amoxicillin/clavulanate in patients hospitalized in the medical ward for community-onset pneumonia?-Author's reply

Clin Microbiol Infect. 2018 Nov;24(11):1224. doi: 10.1016/j.cmi.2018.07.016. Epub 2018 Aug 11.

Authors

E Batard¹, F Javaudin², E Montassier²

Affiliations

¹ Université de Nantes, Microbiotas Hosts Antibiotics Bacterial Resistances (MiHAR), Institut de Recherche en Santé 2, France; CHU Nantes, Emergency Department, Nantes, France. Electronic address: eric.batard@univ-nantes.fr.
² Université de Nantes, Microbiotas Hosts Antibiotics Bacterial Resistances (MiHAR), Institut de Recherche en Santé 2, France; CHU Nantes, Emergency Department, Nantes, France.

PMID: 30107281
DOI: 10.1016/j.cmi.2018.07.016

No abstract available

Publication types

Letter
Comment

MeSH terms

Amoxicillin-Potassium Clavulanate Combination*
Cephalosporins
Humans
Pneumonia*
Prognosis

Substances

Cephalosporins
Amoxicillin-Potassium Clavulanate Combination